JANE ATKINS
Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases SAN ANTONIO, TX NPI 1003852971
Browse related groups: Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Infectious Diseases TX Novo Nordisk AS All categories
General Payments — all program years on this page
$587.64
- Category: General Payments
- Program years: PY2018–2022
- Record count: 27
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $173.29 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.29 | 8 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $50.82 | 3 |
| Medtronic, Inc. | $47.99 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $32.14 | 1 |
| ABBVIE INC. | $24.20 | 1 |
| Supernus Pharmaceuticals, Inc. | $18.14 | 1 |
By program year
Records — PY2022 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 890534521 | ABBVIE INC. | $24.20 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898566201 | Novo Nordisk Inc | $14.07 | 05/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898929411 | Novo Nordisk Inc | $17.59 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 898978785 | Novo Nordisk Inc | $19.16 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 930238225 | Medtronic, Inc. | $25.00 | 11/28/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 952908167 | Supernus Pharmaceuticals, Inc. | $18.14 | 03/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 955587377 | Takeda Pharmaceuticals U.S.A., Inc. | $32.14 | 07/05/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 965243541 | Medtronic, Inc. | $22.99 | 12/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.